10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,544 | -182,627 | -255,099 | -166,000 | -58,223 |
| Depreciation Amortization | 43,816 | 43,708 | 43,619 | 33,006 | 28,254 |
| Accounts receivable | 41,314 | 26,951 | -10,613 | -18,948 | -34,041 |
| Accounts payable and accrued liabilities | -2,126 | -3,354 | -6,017 | 5,858 | 11,084 |
| Other Working Capital | 24,250 | 2,338 | 18,021 | -40,342 | -88,490 |
| Other Operating Activity | 72,340 | 119,648 | 194,892 | 152,820 | 120,043 |
| Operating Cash Flow | $136,050 | $6,664 | $-15,197 | $-33,606 | $-21,373 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,765 | -19,238 | 183,016 | -215,226 | N/A |
| PPE Investments | -5,935 | -12,393 | -48,601 | -131,661 | -101,278 |
| Net Acquisitions | -9,268 | N/A | N/A | -4,000 | -5,451 |
| Purchase Sale Intangibles | N/A | -1,000 | -923 | N/A | N/A |
| Other Investing Activity | 0 | -1,000 | -923 | 0 | 0 |
| Investing Cash Flow | $-13,438 | $-32,631 | $133,492 | $-350,887 | $-106,729 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -5,814 | -5,409 | -5,028 |
| Common Stock Issued | 6,803 | 10,914 | 19,483 | 21,226 | 40,325 |
| Financing Cash Flow | $6,803 | $10,914 | $13,669 | $15,817 | $35,297 |
| Exchange Rate Effect | 484 | -164 | -33 | -44 | 234 |
| Beginning Cash Position | 344,067 | 359,284 | 227,353 | 596,073 | 688,644 |
| End Cash Position | 473,966 | 344,067 | 359,284 | 227,353 | 596,073 |
| Net Cash Flow | $129,899 | $-15,217 | $131,931 | $-368,720 | $-92,571 |
| Free Cash Flow | |||||
| Operating Cash Flow | 136,050 | 6,664 | -15,197 | -33,606 | -21,373 |
| Capital Expenditure | -5,935 | -12,393 | -48,601 | -131,661 | -101,278 |
| Free Cash Flow | 130,115 | -5,729 | -63,798 | -165,267 | -122,651 |